Detector A+ is a brain MRI interpretation and reporting platform that detects suspected tumors, segments lesions, measures volume, localizes brain regions, and classifies five tumor types: acoustic neuroma, meningioma, brain metastasis, pituitary tumor, and glioma. Integrated with DICOM/PACS, it automatically selects T1W+C/T2W images for AI inference and, after physician confirmation, uses an LLM to draft reports, improving efficiency, consistency, and workflow integration.

Detector A+ transforms conventional brain tumor segmentation into an end-to-end intelligent brain MRI interpretation platform. It integrates suspicious lesion detection, five-class tumor classification, automatic segmentation, volumetric measurement, brain-region localization, false-positive filtering, tracking, and DICOM/PACS-based image selection. Physician review and LLM-assisted draft reporting improve clinical efficiency, reporting standardization, and deployment readiness.

Detector A+ supports radiology interpretation, premium health screening, neurosurgical preoperative assessment, radiation oncology planning, and brain tumor follow-up, improving brain MRI reading efficiency and report consistency. It can be integrated with PACS, AI PACS, imaging workstations, and clinical decision-support systems, enabling smart hospital deployment, medical device commercialization, on-premise implementation, and domestic or international market expansion.